Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Matson

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Arthritis Care & Research|August 7, 2025
Heterogeneity of Rheumatoid Arthritis-Associated Interstitial Lung Disease by Longitudinal Forced Vital Capacity Trajectory and Associations with Disease OutcomesBryant R England, Yangyuna Yang, Punyasha Roul, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 6, 2026
Characterization of Pulmonary Functional Abnormalities in Systemic Sclerosis Using Xenon MRIDawson Shaver, Steven Haworth, Evan Graumann, et al.
Thorax|April 10, 2025
Impact of quantitative radiological features of interstitial lung disease on immunomodulatory treatment response in three autoimmune interstitial lung disease cohortsScott M Matson, Grace Hyun J Kim, Stephen M Humphries, et al.
CHEST Pulmonary|September 8, 2025
Pragmatic Comparative Effectiveness Trials in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multiperspective Qualitative StudyAngela Kaczorowski-Worthley, Dinesh Pal Mudaranthakam, Janell Reichuber, et al.
American Journal of Respiratory and Critical Care Medicine|December 7, 2021
Prospective Identification of Subclinical Interstitial Lung Disease in a Rheumatoid Arthritis Cohort Is Associated with the <i>MUC5B</i> Promoter VariantScott M Matson, Kevin D Deane, Anna L Peljto, et al.
The Lancet. Rheumatology|January 10, 2025
Advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease: a retrospective, active-comparator, new-user, cohort studyBryant R England, Joshua F Baker, Michael D George, et al.
Seminars in Arthritis and Rheumatism|April 25, 2025
Non-TNFi biologic and targeted synthetic DMARDs in rheumatoid arthritis-associated interstitial lung disease: A propensity score-matched, active-comparator, new-user studyHalie Frideres, Christopher S Wichman, Jianghu Dong, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2024
Neutrophil extracellular traps linked to idiopathic pulmonary fibrosis severity and survivalScott M Matson, Linh T Ngo, Yui Sugawara, et al.
Chest|September 29, 2024
Airways Abnormalities in a Prospective Cohort of Patients With Rheumatoid ArthritisScott M Matson, Jiwoong Choi, Drayton Rorah, et al.
Iscience|January 14, 2026
Neutrophil degranulation in the lung microenvironment linked to idiopathic pulmonary fibrosis severity and survivalScott M Matson, Linh T Ngo, Yui Sugawara, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Arthritis Care & Research|August 7, 2025
Heterogeneity of Rheumatoid Arthritis-Associated Interstitial Lung Disease by Longitudinal Forced Vital Capacity Trajectory and Associations with Disease OutcomesBryant R England, Yangyuna Yang, Punyasha Roul, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 6, 2026
Characterization of Pulmonary Functional Abnormalities in Systemic Sclerosis Using Xenon MRIDawson Shaver, Steven Haworth, Evan Graumann, et al.
Thorax|April 10, 2025
Impact of quantitative radiological features of interstitial lung disease on immunomodulatory treatment response in three autoimmune interstitial lung disease cohortsScott M Matson, Grace Hyun J Kim, Stephen M Humphries, et al.
CHEST Pulmonary|September 8, 2025
Pragmatic Comparative Effectiveness Trials in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multiperspective Qualitative StudyAngela Kaczorowski-Worthley, Dinesh Pal Mudaranthakam, Janell Reichuber, et al.
American Journal of Respiratory and Critical Care Medicine|December 7, 2021
Prospective Identification of Subclinical Interstitial Lung Disease in a Rheumatoid Arthritis Cohort Is Associated with the <i>MUC5B</i> Promoter VariantScott M Matson, Kevin D Deane, Anna L Peljto, et al.
The Lancet. Rheumatology|January 10, 2025
Advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease: a retrospective, active-comparator, new-user, cohort studyBryant R England, Joshua F Baker, Michael D George, et al.
Seminars in Arthritis and Rheumatism|April 25, 2025
Non-TNFi biologic and targeted synthetic DMARDs in rheumatoid arthritis-associated interstitial lung disease: A propensity score-matched, active-comparator, new-user studyHalie Frideres, Christopher S Wichman, Jianghu Dong, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2024
Neutrophil extracellular traps linked to idiopathic pulmonary fibrosis severity and survivalScott M Matson, Linh T Ngo, Yui Sugawara, et al.
Chest|September 29, 2024
Airways Abnormalities in a Prospective Cohort of Patients With Rheumatoid ArthritisScott M Matson, Jiwoong Choi, Drayton Rorah, et al.
Iscience|January 14, 2026
Neutrophil degranulation in the lung microenvironment linked to idiopathic pulmonary fibrosis severity and survivalScott M Matson, Linh T Ngo, Yui Sugawara, et al.
Pageof 4